Zhanbin Zhong

Production Director

        With over 14 years of GMP manufacturing management experience in biopharmaceuticals, Mr. Zhong has overseen production across all stages, from IND submission and Phase I/II clinical trials to full-scale commercial manufacturing. He possesses extensive expertise in quality control and process optimization for every step of cell therapy manufacturing, and has successfully led multiple EMA and NMPA commercial production site inspections.

        Mr. Zhong has managed GMP manufacturing for more than 30 projects, including CAR-T, CAR-NK, TCR-T, and MSC products, securing over 10 IND approvals for cell therapy products. He has spearheaded the establishment of a suspension, serum-free lentiviral vector production platform achieving world-class quality standards, as well as an automated, semi-closed immune cell manufacturing platform approved by the NMPA for Phase II clinical trials.

        He has led multiple “zero-to-one” initiatives, including building new GMP facilities, establishing production teams, and developing complete GMP manufacturing systems. With in-depth knowledge of upstream cell culture, downstream purification, and aseptic fill-finish processes, Mr. Zhong brings a wealth of experience in sterile manufacturing techniques to ensure product quality and regulatory compliance.